OBJECTIVES: To report phenotypic characteristics of 32 age-validated supercentenarians. DESIGN: Case series. SETTING: U.S.-based recruitment effort. PARTICIPANTS: Thirty-two supercentenarians. MEASUREMENTS: Multiple forms of proof were used to validate age claims. Sociodemographic, activities of daily living, and medical history data were collected. RESULTS: Age range was 110 to 119. Fifty-nine percent had Barthel Index scores in the partially to totally dependent range, whereas 41% required minimal assistance or were independent. Few subjects had a history of clinically evident vascular-related diseases, including myocardial infarction (n=2, 6%) and stroke (n=4, 13%). Twenty-two percent (n=7) were taking medications for hypertension. Twenty-five percent (n=8) had a history of cancer (all cured). Diabetes mellitus (n=1, 3%) and Parkinson's disease (n=1, 3%) were rare. Osteoporosis (n=14, 44%) and cataract history (n=28, 88%) were common. CONCLUSION: Data collected thus far suggest that supercentenarians markedly delay and even escape clinical expression of vascular disease toward the end of their exceptionally long lives. A surprisingly substantial proportion of these individuals were still functionally independent or required minimal assistance.
OBJECTIVES: To report phenotypic characteristics of 32 age-validated supercentenarians. DESIGN: Case series. SETTING: U.S.-based recruitment effort. PARTICIPANTS: Thirty-two supercentenarians. MEASUREMENTS: Multiple forms of proof were used to validate age claims. Sociodemographic, activities of daily living, and medical history data were collected. RESULTS: Age range was 110 to 119. Fifty-nine percent had Barthel Index scores in the partially to totally dependent range, whereas 41% required minimal assistance or were independent. Few subjects had a history of clinically evident vascular-related diseases, including myocardial infarction (n=2, 6%) and stroke (n=4, 13%). Twenty-two percent (n=7) were taking medications for hypertension. Twenty-five percent (n=8) had a history of cancer (all cured). Diabetes mellitus (n=1, 3%) and Parkinson's disease (n=1, 3%) were rare. Osteoporosis (n=14, 44%) and cataract history (n=28, 88%) were common. CONCLUSION: Data collected thus far suggest that supercentenarians markedly delay and even escape clinical expression of vascular disease toward the end of their exceptionally long lives. A surprisingly substantial proportion of these individuals were still functionally independent or required minimal assistance.
Authors: C Franceschi; L Motta; S Valensin; R Rapisarda; A Franzone; M Berardelli; M Motta; D Monti; M Bonafè; L Ferrucci; L Deiana; G M Pes; C Carru; M S Desole; C Barbi; G Sartoni; C Gemelli; F Lescai; F Olivieri; F Marchegiani; M Cardelli; L Cavallone; P Gueresi; A Cossarizza; L Troiano; G Pini; P Sansoni; G Passeri; R Lisa; L Spazzafumo; L Amadio; S Giunta; R Stecconi; R Morresi; C Viticchi; R Mattace; G De Benedictis; G Baggio Journal: Aging (Milano) Date: 2000-04
Authors: Stacy L Andersen; Paola Sebastiani; Daniel A Dworkis; Lori Feldman; Thomas T Perls Journal: J Gerontol A Biol Sci Med Sci Date: 2012-01-04 Impact factor: 6.053
Authors: Thomas Perls; Iliana V Kohler; Stacy Andersen; Emily Schoenhofen; JaeMi Pennington; Robert Young; Dellara Terry; Irma T Elo Journal: J Gerontol A Biol Sci Med Sci Date: 2007-09 Impact factor: 6.053
Authors: Kaare Christensen; Matt McGue; Inge Petersen; Bernard Jeune; James W Vaupel Journal: Proc Natl Acad Sci U S A Date: 2008-08-18 Impact factor: 11.205
Authors: Paola Sebastiani; Monty Montano; Annibale Puca; Nadia Solovieff; Toshio Kojima; Meng C Wang; Efthymia Melista; Micah Meltzer; Sylvia E J Fischer; Stacy Andersen; Stephen H Hartley; Amanda Sedgewick; Yasumichi Arai; Aviv Bergman; Nir Barzilai; Dellara F Terry; Alberto Riva; Chiara Viviani Anselmi; Alberto Malovini; Aya Kitamoto; Motoji Sawabe; Tomio Arai; Yasuyuki Gondo; Martin H Steinberg; Nobuyoshi Hirose; Gil Atzmon; Gary Ruvkun; Clinton T Baldwin; Thomas T Perls Journal: PLoS One Date: 2009-12-14 Impact factor: 3.240